Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Adma Biologics (ADMA) Tax Provisions (2024 - 2025)

Historic Tax Provisions for Adma Biologics (ADMA) over the last 4 years, with Q3 2025 value amounting to $11.1 million.

  • Adma Biologics' Tax Provisions rose 121988.1% to $11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$53.7 million, marking a year-over-year decrease of 112741.19%. This contributed to the annual value of -$72.0 million for FY2024, which is N/A changed from last year.
  • Per Adma Biologics' latest filing, its Tax Provisions stood at $11.1 million for Q3 2025, which was up 121988.1% from $5.9 million recorded in Q2 2025.
  • In the past 5 years, Adma Biologics' Tax Provisions registered a high of $11.1 million during Q3 2025, and its lowest value of -$77.2 million during Q4 2024.